EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026

📅 22 Jun – 25 Jun 2026 📍 Trinity Conference Centre, Dublin, Ireland 🏢 0 exhibitors 👥 0 attendees

🎯 Selling to this event's audience? Get a free tailored buyer list

Tell us your work email and our AI instantly builds a buyer list matched to EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.

🔒 Get my buyer details Free · ~20 seconds

About this event

EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026

Event type: Medicinal Chemistry, Drug Discovery, Pharmaceutical R&D, Translational Science, Life Sciences Conference

Estimated attendance: 700–1,500+ delegates depending on final program, host city, and sponsor strength. This type of scientific congress usually attracts a concentrated, high-value audience rather than mass footfall.

Overall buyer profile: This is a highly specialized, research-led conference focused on medicinal chemistry and drug discovery. The best buyers are not general attendees; they are people and organizations directly involved in molecule design, lead optimization, preclinical development, translational research, and pharma innovation. The strongest audience is typically made up of pharmaceutical companies, biotech firms, CROs, academic research groups, and platform technology providers.

1️⃣ Who attends: Buyers / Attendees

This event attracts a technical, scientific, and innovation-driven audience. The most relevant attendees are decision-makers and influencers involved in drug discovery and medicinal chemistry workflows. It is especially useful for companies selling research tools, software, lab technologies, assay systems, analytical instruments, CRO services, AI-driven drug discovery platforms, and scientific consulting.

Main attendee groups:

  • Medicinal chemists, senior scientists, and principal investigators
  • Drug discovery directors, heads of chemistry, and R&D leaders
  • Pharma innovation teams and translational research managers
  • Biotech founders, CSOs, and research program managers
  • Preclinical development and lead optimization specialists
  • Computational chemists, structural biologists, and bioinformatics teams
  • CRO and CDMO business development leaders
  • Analytical chemistry, screening, and assay development professionals
  • Academic researchers, postdocs, and graduate-level scientists
  • Vendors supplying instruments, reagents, lab automation, and software

The strongest buyers are usually not end consumers. They are organizations with budgets for scientific services, lab infrastructure, partnerships, licensing, compound libraries, and discovery platforms. That makes this event very valuable for B2B outreach.

2️⃣ Where the show is happening + attendee geographic origin

Event location: The final venue may vary depending on the host city selected for 2026. This conference series is usually positioned as an international European-style scientific forum with broad cross-border participation.

Attendee geographic origin: The audience is typically international, with strong representation from Europe, the United Kingdom, North America, and selected Asia-Pacific life sciences hubs. A meaningful portion of attendees generally come from:

  • Pharmaceutical clusters in Switzerland, Germany, the United Kingdom, France, and the Netherlands
  • U.S. biotech and pharma centers such as Boston, San Diego, New Jersey, and the Bay Area
  • Academic and research institutions across Europe and North America
  • Global CROs and life sciences service providers with cross-border business development teams

Best geographic targeting:

  • Global outreach is the right strategy here
  • Priority should go to Europe and North America
  • Secondary focus on Israel, Singapore, Japan, South Korea, and other advanced research markets

3️⃣ Audience reach: Local / National / Global

Reach type: Global

This is clearly an international scientific conference, not a local trade show. The audience is likely dispersed across several countries and includes both academic and commercial stakeholders. Because of the technical subject matter, the event has a strong global reputation within medicinal chemistry and drug discovery circles.

For list-building purposes, this means the event is suitable for international buyer segmentation, not just one-country targeting. The attendee list can include global scientific buyers, regional business development leaders, and research decision-makers from multiple countries.

4️⃣ Sample buyer company names + websites

Below is a sample buyer-style list of organizations that are highly relevant to this event. These are buyer accounts, not random names. They represent likely purchasers of scientific services, technology, laboratory tools, software, or partnership opportunities related to medicinal chemistry and drug discovery.

Priority Company Website Best Title to Target Why This is a Good Buyer Fit
1 Novartis novartis.com Head of Medicinal Chemistry / Director of Drug Discovery / External Innovation Manager Global pharma leader with continuous demand for discovery platforms, chemistry expertise, and translational partnerships.
2 Roche roche.com Discovery Research Director / Therapeutic Area Lead / Scientific Partnerships Manager Strong fit for early-stage research, biomarker-driven discovery, and scientific collaboration.
3 Pfizer pfizer.com Vice President, Medicinal Chemistry / Research Program Lead / External R&D Director Large-scale drug discovery organization with broad interest in chemistry, screening, and platform innovation.
4 Merck & Co. merck.com Head of Discovery Chemistry / Senior Scientist, Lead Optimization / Alliance Manager Highly relevant for medicinal chemistry, lead optimization, and scientific collaboration.
5 AstraZeneca astrazeneca.com Director, Small Molecule Discovery / Research Collaboration Lead / Chemistry Program Manager Excellent buyer profile for innovative chemistry, screening, AI platforms, and pipeline development.
6 GSK gsk.com Head of Chemistry / Drug Discovery Strategy Lead / External Research Partnerships Manager Strong scientific buyer base with ongoing need for discovery tools and partnerships.
7 Bristol Myers Squibb bms.com Director, Discovery Chemistry / Research Project Leader / Innovation Sourcing Manager Good fit for complex therapeutic research and sourcing of scientific technologies and services.
8 Sanofi sanofi.com Global Head of Medicinal Chemistry / Early Discovery Leader / Scientific Alliance Director Broad interest in small-molecule discovery, translational science, and collaborative R&D.
9 Amgen amgen.com Senior Director, Discovery Research / Chemistry Platform Lead / External Innovation Manager Strong biotech-pharma hybrid buyer with deep investment in discovery and platform capabilities.
10 AbbVie abbvie.com Director, Medicinal Chemistry / Therapeutics Research Director / Business Development, Research Relevant for discovery chemistry, therapeutic innovation, and research collaboration sourcing.
11 Takeda takeda.com Head of Discovery Sciences / Chemistry Program Director / Alliance Management Lead International buyer with strong R&D and external partnership activity.
12 BioNTech biontech.com Director, Small Molecule Discovery / Translational Research Lead / Scientific Collaboration Manager Highly innovative biotech with interest in advanced discovery platforms and cross-functional research.
13 Evotec evotec.com Business Development Director / Head of Discovery Services / Chemistry Operations Lead CRO/platform-science model makes this a strong buyer for tools, services, and technology partnerships.
14 Charles River Laboratories criver.com Vice President, Discovery Services / Medicinal Chemistry Services Lead / Alliance Manager Excellent CRO buyer for discovery services, chemistry support, and client-facing scientific solutions.
15 Cytiva cytivalifesciences.com Strategic Account Manager / Product Marketing Manager / Scientific Sales Director Supplier-side buyer for lab technologies, workflows, and research platform integration.
16 Thermo Fisher Scientific thermofisher.com Market Development Manager / Drug Discovery Sales Director / Life Sciences Partnerships Lead Strong fit for instruments, reagents, analytical systems, and workflow solutions.
17 WuXi AppTec wuxiapptec.com Business Development Director / Head of Discovery Chemistry Services / Strategic Alliances Manager Major service provider in drug discovery with direct commercial interest in scientific buyer acquisition.
18 Sotio Biotech sotio.com Research Director / Translational Science Lead / Alliance Manager Biotech buyer with needs in medicinal chemistry, therapeutic innovation, and scientific outsourcing.
19 C4X Discovery c4xdiscovery.com Head of Drug Discovery / Partnering Director / CSO Discovery-focused organization with a direct need for chemistry-driven partnerships and platforms.
20 BioCryst Pharmaceuticals biocryst.com Senior Director, Discovery Chemistry / R&D Program Lead / Business Development Manager Small to mid-size pharma profile with strong relevance for drug discovery and scientific collaboration.

Top 5 buyer samples to prioritize first: Novartis, Roche, Pfizer, AstraZeneca, and Charles River Laboratories. These are the strongest mix of pharma, research, and service buyers with real relevance to the conference theme.

5️⃣ Job profiles, industries & event type

Best job titles to target:

  • Head of Medicinal Chemistry
  • Director of Drug Discovery
  • Senior Scientist, Medicinal Chemistry
  • Research Program Director
  • Discovery Chemistry Lead
  • Vice President, R&D
  • Translational Research Director
  • Alliance Management Director
  • Business Development Director, Life Sciences
  • External Innovation Manager
  • Principal Scientist, Lead Optimization
  • Computational Chemistry Lead
  • Screening and Assay Development Manager
  • Scientific Partnership Manager
  • Laboratory Automation Product Manager
  • Drug Discovery Platform Lead

Best industry filters from your industry list:

  • Pharmaceuticals
  • Biotechnology
  • Research
  • Hospital & Health Care
  • Medical Devices
  • Information Technology & Services
  • Computer Software
  • Information Services
  • Management Consulting
  • Market Research
  • Higher Education
  • Education Management
  • Professional Training & Coaching
  • Laboratories and scientific services can also be inferred through company keywords if industry tags are not exact

Event type classification: Scientific conference, R&D networking event, drug discovery congress, medicinal chemistry forum, partnership-building event, innovation showcase.

6️⃣ Estimated attendance: expected total footfall

Estimated attendance: 700–1,500+ delegates

This range is appropriate for a specialized conference of this type. The event is not built for mass consumer attendance. Instead, it attracts a smaller but much more qualified audience. That means the list may be smaller than a large trade show, but the buyer quality is significantly higher.

Footfall composition may include:

  • Scientific delegates and presenters
  • Academic attendees and student researchers
  • Pharma and biotech exhibitors
  • Sponsored solution providers
  • Panelists, keynote speakers, and advisory board members
  • Business development and partnership teams

7️⃣ Key focus areas & buyer engagement

Key focus areas:

  • Medicinal chemistry innovation
  • Lead discovery and lead optimization
  • Small molecule design and synthesis
  • Hit-to-lead workflows
  • Computational chemistry and AI-enabled discovery
  • Assay development and screening
  • Translational science
  • Preclinical development strategy
  • Scientific partnerships and outsourcing
  • Platform technologies for life sciences R&D

Buyer engagement angle: The best engagement strategy is to position the attendee list as a highly targeted scientific and commercial database, not a generic conference list. Buyers attending this event are likely to respond to outreach involving:

  • Discovery chemistry solutions
  • Analytical and screening platforms
  • Scientific software and data tools
  • Research collaboration opportunities
  • CRO/CDMO services
  • Lab automation and workflow optimization
  • Specialized lab equipment and reagents

This audience is especially good for companies that can speak the language of science, innovation, and productivity. Generic sales messaging will not work well here.

8️⃣ Client-product fit note

Very important: Please share your client website before finalizing the best buyer list. The ideal accounts for this event depend heavily on the client’s product or service.

Examples:

  • If the client sells lab instruments, target pharma and biotech R&D leaders, screening managers, and scientific procurement teams.
  • If the client sells software, target computational chemists, discovery informatics leaders, and research platform managers.
  • If the client sells CRO/CDMO or consulting services, target biotech founders, alliance managers, and external innovation teams.
  • If the client sells reagents, assay kits, or workflow products, target lab heads, assay development teams, and principal scientists.
  • If the client sells hiring, staffing, or recruitment solutions, target HR, talent acquisition, and scientific operations leaders in pharma and biotech.

Best next step: Send the client website, product category, and ideal customer profile so the buyer list can be filtered to match real purchase intent.

9️⃣ Final recommendation

This is a strong event for premium B2B attendee-list sales because the audience is highly specialized, professionally relevant, and commercially valuable. While the attendance size may be moderate compared with a large exhibition, the quality of contacts is much higher.

Best buyer segments to collect:

  • Pharma R&D leadership
  • Medicinal chemistry teams
  • Drug discovery directors
  • Biotech scientific founders and CSOs
  • CRO business development leaders
  • Academic researchers and lab heads
  • Scientific software, tools, and platform vendors

Quality rating for B2B attendee-list sales: 9/10

Excellent for a highly targeted, research-driven audience. Best suited for clients selling scientific tools, services, software, instruments, consulting, and innovation partnerships.

Data sheet

EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 – Event Attendee & Buyer Profile Analysis
Event date: 22 June 2026 – 25 June 2026
Location: Trinity Conference Centre, Dublin, County Dublin, Ireland
Event status: Ongoing
Research date: 22 June 2026
Event Overview
Event Name EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026
Event Date 22 June 2026 – 25 June 2026
Event Status Ongoing
Venue Trinity Conference Centre
City Dublin
State / Region County Dublin
Country Ireland
Organizer EFMC and ACS MEDI are strongly indicated by the event branding; specific local organizing entity should be confirmed on the official event page.
Official Event Website See Sources & Verification Notes for official organization and venue links.
Event Type Medicinal chemistry, drug discovery, pharmaceutical R&D, translational science, life sciences conference
Primary Category Medical & Pharma
Secondary Applicable Categories Science & Research; IT & Technology
Audience Reach Likely global specialist reach with strong European and North American scientific participation
Estimated Attendance / Expected Footfall Estimated 700–1,500+ delegates based on specialist medicinal chemistry congress benchmarks and the user-supplied event brief
Attendance Data Reliability Estimated. Attendance figure not publicly confirmed by the organizer in the material available for this report.
Main Purpose of Event To connect medicinal chemistry and drug discovery professionals across pharma, biotech, academia, CROs, platform providers, and translational research teams for scientific exchange, partnership development, and technology evaluation.
About the Event

EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 is a specialist scientific conference centered on medicinal chemistry, lead discovery, molecule optimization, translational science, and the broader pharmaceutical R&D workflow. The event theme and branding indicate a high-level meeting point for medicinal chemists, discovery scientists, biotech innovators, and research leadership rather than a broad commercial expo with general visitor traffic.

From a lead-generation perspective, the event matters because it attracts technically qualified and commercially influential participants involved in early-stage to preclinical drug development decisions. The strongest opportunities are typically with pharmaceutical R&D leaders, biotech platform teams, contract research organizations, translational institutes, and providers of AI drug discovery tools, scientific software, assay platforms, analytical technologies, outsourced chemistry, and partnership-led innovation services.

1. Who Attends: Buyers / Attendees
Buyer / Attendee Segment Typical Organizations Buying Role or Influence Relevance to Exhibitors / Suppliers
Medicinal chemistry leaders Pharma R&D groups, biotech discovery teams, translational research programs Influence platform selection, chemistry outsourcing, compound design workflows, and scientific collaborations High relevance for CRO services, compound libraries, computational chemistry, analytical instrumentation, and AI platforms
Drug discovery directors and heads of chemistry Mid-size and large pharma, venture-backed biotech, integrated discovery organizations Approve budgets, evaluate discovery partners, prioritize pipeline-enabling technologies Very strong fit for enterprise and strategic sales conversations
Translational science and preclinical teams Academic medical research centers, translational institutes, biotech R&D units Shape assay selection, target validation, preclinical workflow, external study purchasing High relevance for assays, bioanalytics, in vitro and in vivo services, and translational data tools
CRO and outsourcing buyers Pharma, biotech, university spinouts, virtual biotech companies Source medicinal chemistry support, hit-to-lead, DMPK, toxicology, and synthesis capacity High relevance for outsourced research, specialist chemistry, and integrated discovery partnerships
Computational chemistry and AI drug discovery teams Biotech platform companies, pharma informatics teams, digital biology groups Evaluate software, data infrastructure, modeling tools, and external platforms Strong fit for software vendors, cloud partners, data providers, and AI solution providers
Principal investigators and academic group leaders Universities, institutes, publicly funded research centers Influence grant-funded purchasing, collaborative studies, licensing pathways Strong relevance for instruments, reagents, databases, and translational partnerships
Business development and alliance management teams Pharma, biotech, platform technology firms, CROs Identify licensing, co-development, and strategic partnership opportunities Very relevant for partnership-led outreach and meetings
Scientific procurement and lab operations stakeholders Research institutions, pharma labs, biotech facilities Manage purchasing of instruments, informatics subscriptions, consumables, and specialized service contracts Good fit for lab vendors and support service providers
Investors and technology scouts Life sciences investors, innovation offices, venture creation teams Assess commercial potential of platforms and pipeline assets Relevant for strategic introductions and platform visibility, though not always direct purchasers
2. Event Location and Attendee Geographic Origin
Geographic Area Likely Attendee Origin Buyer Concentration Notes
Dublin Local university researchers, biotech professionals, pharma-linked research staff Moderate to high Host-city attendance should be reinforced by nearby academic and life sciences communities
County Dublin / Greater Dublin Area Regional R&D, translational science, and laboratory operations attendees High Likely concentration of biotech, pharma support services, and research institutes
Ireland National pharma manufacturing, R&D, university, and translational research delegates High Ireland’s pharmaceutical and biotech footprint supports strong domestic relevance
United Kingdom Likely inbound scientific and commercial attendees from pharma, biotech, and universities High Short travel corridor and strong medicinal chemistry base make the UK a likely feeder market
Continental Europe Scientists and R&D leaders from EFMC-linked networks and European discovery organizations Very high Expected core international audience segment based on event branding and topic area
North America Selected pharma, biotech, and ACS-linked scientific participants Moderate More concentrated, high-value delegation rather than mass attendance
Other international markets Selective participation from Asia-Pacific and global innovation centers Low to moderate Possible where global platform providers, pharma alliances, or invited speakers are involved
3. Audience Reach
Reach Level Assessment Explanation
Global Primary classification The EFMC and ACS MEDI branding indicates an internationally relevant medicinal chemistry audience, with likely participation from Europe, the UK, Ireland, and North America.
European specialist reach Secondary description The strongest concentration is likely to be Europe-based medicinal chemistry, drug discovery, and translational research professionals.
4. Sample Buyer Companies and Websites
Public current-year attendee or buyer-company lists were not publicly confirmed in the material available for this report. The table below is therefore presented as prospecting-oriented buyer targets with strong thematic fit to medicinal chemistry and drug discovery in Ireland, the UK, Europe, and global pharma/biotech networks. These organizations are not claimed as confirmed attendees.
Buyer Company / Organization Buyer Type Why It Is Relevant Website Best Job Titles to Target Evidence Level
Pfizer Pharmaceutical company Major discovery and development organization relevant to medicinal chemistry and translational science pfizer.com Head of Medicinal Chemistry, Senior Director Drug Discovery, Procurement Manager R&D Strong Market Fit, Attendance Not Confirmed
Eli Lilly and Company Pharmaceutical company Active in small-molecule and discovery programs relevant to conference themes lilly.com Director Medicinal Chemistry, Discovery Biology Lead, Strategic Sourcing Manager Strong Market Fit, Attendance Not Confirmed
Novartis Pharmaceutical company Global buyer of discovery technologies, CRO services, and translational capabilities novartis.com Executive Director Chemistry, Head of Discovery Partnerships, Procurement Category Manager Strong Market Fit, Attendance Not Confirmed
AstraZeneca Pharmaceutical company Strong medicinal chemistry, oncology, and translational science relevance astrazeneca.com Director Discovery Sciences, Medicinal Chemistry Lead, External Innovation Manager Strong Market Fit, Attendance Not Confirmed
GSK Pharmaceutical company Relevant for chemistry platforms, externalized discovery, and R&D collaboration gsk.com VP Drug Discovery, Director Medicinal Chemistry, R&D Procurement Lead Strong Market Fit, Attendance Not Confirmed
Boehringer Ingelheim Pharmaceutical company Strong fit for discovery chemistry, assay systems, and preclinical workflow providers boehringer-ingelheim.com Head of Chemistry, Discovery Procurement Manager, Alliance Manager Strong Market Fit, Attendance Not Confirmed
Johnson & Johnson Innovative Medicine Pharmaceutical company Relevant buyer of drug discovery platforms, data tools, and external research capabilities jnj.com Scientific Director, Translational Science Lead, Strategic Sourcing Director Strong Market Fit, Attendance Not Confirmed
Evotec Drug discovery partner / CRO Highly relevant for integrated discovery, chemistry services, and partnership discussions evotec.com SVP Drug Discovery, Business Development Director, Alliance Director Strong Market Fit, Attendance Not Confirmed
WuXi AppTec R&D services provider Relevant for outsourced medicinal chemistry, biology, and preclinical support buying and selling activity wuxiapptec.com Business Development Director, Head of Discovery Services, Alliance Lead Strong Market Fit, Attendance Not Confirmed
Charles River Laboratories Preclinical and discovery services provider Relevant to preclinical buyers and partnership-driven attendees criver.com Director Discovery Services, Preclinical Partnerships Lead, Procurement Lead Strong Market Fit, Attendance Not Confirmed
Trinity College Dublin Academic research institution Host-city scientific institution with strong relevance to medicinal chemistry and translational research collaboration tcd.ie Principal Investigator, Research Centre Director, Lab Operations Manager Strong Market Fit, Attendance Not Confirmed
University College Dublin Academic research institution Potential source of translational science attendees and grant-funded purchasing influence ucd.ie PI Medicinal Chemistry, Research Program Director, Procurement Officer Strong Market Fit, Attendance Not Confirmed
5. Job Profiles, Industries and Event Type
Priority Job Title / Function Department Seniority Level Why This Role Matters
1 Head of Medicinal Chemistry R&D / Discovery Director / VP Direct owner of chemistry strategy, platform evaluation, and external collaboration
2 Drug Discovery Director R&D / Discovery Director High-value buyer and influencer for integrated discovery capabilities
3 Principal Scientist / Senior Scientist Medicinal Chemistry / Biology Manager / Senior Individual Contributor Often drives technical shortlisting and vendor recommendation
4 Translational Science Lead Translational Research Director / Senior Manager Relevant for assay, biomarker, preclinical, and workflow solutions
5 Director of External Innovation / Alliances Business Development Director / VP Key for partnership-led sales and co-development opportunities
6 Strategic Sourcing Manager Procurement Manager Important where the sale involves enterprise contracts, CRO outsourcing, or lab platforms
7 Lab Operations Manager Laboratory Operations Manager Relevant buyer for instrument, software, and operational support solutions
8 Computational Chemistry Lead Informatics / Discovery Senior Manager / Director Key target for AI, modeling, and scientific data solutions
9 Business Development Director Business Development Director Common at CROs, platforms, and biotech firms seeking collaborations and outsourced services
10 Principal Investigator Academic Research Faculty / Research Lead Important for grant-funded purchases, translational partnerships, and early innovation access
Priority Apollo Industry Why It Fits the Event Best Buyer Use Case
1 Pharmaceuticals Core buyer base for medicinal chemistry and drug discovery solutions Platform evaluation, outsourcing, discovery collaboration
2 Biotechnology Strong fit for venture-backed and innovation-led discovery organizations AI discovery, CRO partnerships, assay and chemistry support
3 Research Covers translational and scientific institutes participating in preclinical and medicinal chemistry work Collaborative research, instrumentation, data resources
4 Higher Education Universities are important scientific contributors and research buyers Lab equipment, software, collaboration and grants
5 Medical Devices Relevant for analytical, assay, and adjacent translational technology suppliers Scientific instrumentation and workflow integration
6 Computer Software Relevant for molecular modeling, ELN/LIMS, and AI-enabled chemistry tools Scientific software, workflow digitization, cheminformatics
7 Information Technology & Services Supports data platforms, cloud environments, and scientific computing vendors Data integration, scientific cloud, AI support
8 Hospital & Health Care Relevant where translational medicine and clinical-adjacent research institutes are involved Biomarker and translational workflow partnerships
9 Management Consulting Relevant to specialist life sciences and R&D strategy advisors attending for partnership sourcing Innovation scouting and market intelligence
10 Events Services Useful only for partner ecosystem mapping around scientific event sponsors and organizers Sponsorship and event partnership targeting
6. Estimated Attendance
Metric Figure Status Source / Basis Notes
Estimated total footfall 700–1,500+ Estimated User-supplied event brief and comparable specialist congress benchmark High-value specialist event; not a mass-footfall expo
Exhibitor count Not publicly confirmed Unconfirmed Organizer figure not available in source material reviewed Could include sponsors, platform vendors, CROs, and instrument providers
Buyer count Not publicly confirmed Unconfirmed No official buyer program count identified Scientific conferences typically do not publish “buyer” counts in trade-show format
Speaker count Not publicly confirmed Unconfirmed Agenda count not available in source material reviewed Expected to be material for a four-day specialist program
Sponsor count Not publicly confirmed Unconfirmed No validated sponsor list available for this report Sponsors would likely include CROs, software vendors, and research suppliers
Historical attendance Not publicly confirmed Historical / prior-year evidence unavailable in reviewed material No prior-year verified attendance figure used Avoiding unsupported carryover claims
7. Key Focus Areas and Buyer Engagement
Focus Area Typical Buyer Need Buyer Engagement Opportunity Relevant Supplier Offering
Medicinal chemistry Lead optimization, SAR support, synthesis quality, workflow acceleration Scientific demos, chemistry partnership meetings, technical consultations CRO chemistry services, synthesis platforms, compound design tools
Drug discovery Hit identification, target validation, integrated discovery workflows Partnership sourcing and pipeline-enablement discussions Discovery platforms, assays, screening, integrated CRO support
Translational science Biomarker relevance, preclinical translation, model systems Research collaboration and grant-linked procurement discussions Bioanalytical services, translational platforms, disease models
AI and computational chemistry Molecular modeling, prediction, prioritization, design efficiency Software evaluations and innovation scouting AI drug discovery, cheminformatics, cloud compute, data tools
Analytical and assay technologies Data quality, throughput, reproducibility, characterization Instrument and platform discussions with scientific users and lab operations Analytical instrumentation, assay kits, automation, lab software
Partnerships and external innovation Access to novel science, discovery partners, platform collaborations Alliance meetings, BD networking, co-development opportunities Platform licensing, services partnerships, co-research models
Lead Quality Assessment
Factor Assessment Explanation
Buyer relevance Very High Audience is highly specialized and aligned with medicinal chemistry, drug discovery, and translational research buying needs.
Decision-maker availability High Scientific leaders, research directors, and BD stakeholders are likely present, though not all attendees will hold direct procurement authority.
Data collection potential Medium Scientific conferences often limit public attendee disclosure, reducing list-building transparency versus trade expos.
Apollo targeting potential Very High Pharma, biotech, research, and software-related segments can be targeted effectively by function and seniority.
Geographic targeting potential High Ireland, the UK, and Europe provide a practical first-wave prospect geography; North America can be layered in for broader reach.
Best outreach approach High Use scientific-value messaging, partnership framing, and workflow problem-solving rather than generic event-sales language.
Overall lead quality High Quality is strong for specialized B2B prospecting, though current-year public attendance validation is limited.
Best use case High Best for account-based outreach, scientific partnership targeting, and niche R&D buyer profiling rather than mass attendee-list sales.
Limitations / risks Medium Public attendee confirmation may be scarce; many participants influence buying technically but do not sign contracts directly.
Apollo.io Targeting Recommendation
Filter Type Recommended Filters Purpose
Apollo industries Pharmaceuticals; Biotechnology; Research; Higher Education; Medical Devices; Computer Software; Information Technology & Services; Hospital & Health Care Build the core target universe aligned with medicinal chemistry and translational science
Departments Research, Engineering, Information Technology, Operations, Business Development, Purchasing, Program Management Reach both technical evaluators and commercial decision-makers
Seniority Director, VP, Head, CXO, Partner, Owner, Manager, Principal Focus on budget holders and high-influence scientific leaders
Job titles Head of Medicinal Chemistry; Director Drug Discovery; Principal Scientist; Senior Scientist; Head of Chemistry; Translational Science Lead; Director External Innovation; Alliance Manager; Strategic Sourcing Manager; Lab Operations Manager; Computational Chemistry Lead; Business Development Director Precision targeting by workflow responsibility and buying influence
Geography Ireland, United Kingdom, Germany, Switzerland, France, Netherlands, Belgium, Denmark, Sweden, United States Prioritize the most likely event-linked and medicinal chemistry-active markets
Employee size 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ Capture both venture-backed biotech and enterprise pharma buyers
Keywords medicinal chemistry, drug discovery, lead optimization, translational science, preclinical, cheminformatics, computational chemistry, assay development, hit-to-lead, small molecule, DMPK Improve relevance where industry labels are too broad
Technologies, if relevant LIMS, ELN, cheminformatics, cloud computing, AI/ML platforms, screening automation Useful for software, data, and workflow infrastructure targeting
Revenue range, if relevant $1M–$10M, $10M–$50M, $50M–$500M, $500M+ Segment emerging biotech from enterprise pharma accounts
Company type Public company, private company, nonprofit research institution, university Support account segmentation by funding and procurement behavior
Funding / public company filters, if relevant Recently funded biotech, publicly listed pharma, venture-backed R&D platform firms Identify active buyers with current budget or partnership momentum
Suggested Apollo Search Logic: ("medicinal chemistry" OR "drug discovery" OR "lead optimization" OR "small molecule" OR "translational science" OR "computational chemistry" OR cheminformatics OR preclinical) AND (Director OR Head OR VP OR Principal OR Manager) AND (Pharmaceuticals OR Biotechnology OR Research OR Higher Education). For vendor-facing opportunities, add keywords such as "external innovation," "alliance management," "strategic sourcing," "R&D procurement," or "discovery partnerships."
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
Source Type What It Verified Reliability
European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Official organization website Validated EFMC as an official medicinal chemistry conference organization relevant to the event branding High
American Chemical Society (ACS) Official organization website Validated ACS as the parent scientific body connected to ACS MEDI branding High
Trinity Conference Centre Official venue website Venue reference for Trinity Conference Centre, Dublin High
User-supplied event brief Provided source material Confirmed event title, city, region, country, venue, and event date range; supplied attendance estimate and thematic description Medium to High
Subject-matter benchmark analysis Analyst assessment Estimated attendance range, likely attendee profile, and Apollo targeting logic based on specialist medicinal chemistry congress norms Medium
Note: Current-year public attendee, buyer, sponsor, and exhibitor lists were not publicly confirmed in the source material available for this report. This event is suitable for specialized B2B attendee profiling and account-based outreach, but less suitable for guaranteed current-year attendee list building unless the organizer publishes participant directories or sponsor/exhibitor rosters.

🎯 Selling to this event's audience? Get a free tailored buyer list

Tell us your work email and our AI instantly builds a buyer list matched to EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.

🔒 Get my buyer details Free · ~20 seconds
Chat with us
We usually reply quickly